Cerus (CERS) Announces Pathogen Reduction Technology Included in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets
Tweet Send to a Friend
Cerus Corporation (NASDAQ: CERS) announced that the U.S. Food and Drug Administration (FDA) has issued a revised draft guidance document ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
